Read + Share
Amitai I, Roos K, Rashedi I, Jiang Y, et al. PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S,
pembrolizumab, and low-dose CPA in R/R DLBCL. Eur J Haematol 2023;111:191-200.
PMID: 37157906
|
 |
|
Amitai I, Roos K, Rashedi I, Jiang Y, et al. PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S,
pembrolizumab, and low-dose CPA in R/R DLBCL. Eur J Haematol 2023;111:191-200.
PMID: 37157906
|
|
|
|